| Q36539414 | A preliminary method development study to identify potential stroke biomarkers in plasma using multiple chromatographies with nanoLC-ESIMS detection |
| Q35063527 | Assessing the quality and reproducibility of a proteomic platform for clinical stroke biomarker discovery |
| Q48509677 | Biomarker level improves the diagnosis of embolic source in ischemic stroke of unknown origin |
| Q35125900 | Biomarker panels in ischemic stroke. |
| Q37903591 | Blood biomarkers for the diagnosis of acute cerebrovascular diseases: a prospective cohort study |
| Q37998544 | Blood biomarkers in stroke: research and clinical practice |
| Q39269033 | Blood-based protein biomarkers for stroke differentiation: A systematic review |
| Q93039067 | Candidate Biomarkers for the Diagnosis of Transient Ischemic Attack: A Systematic Review |
| Q38648651 | Capillary blood for point-of-care testing |
| Q47206216 | Cell-free DNA as a biomarker in stroke: Current status, problems and perspectives |
| Q35137635 | Central nervous system agents for ischemic stroke: neuroprotection mechanisms |
| Q37688066 | Clinical application of blood biomarkers in cerebrovascular disease |
| Q35503036 | Correlation between Serum D-Dimer Level and Volume in Acute Ischemic Stroke |
| Q26744505 | Current status of biomarker research in neurology |
| Q57478637 | Differential MicroRibonucleic Acid Expression in Cardioembolic Stroke |
| Q48204595 | Effects of carnosine on polyamine levels in red blood cells of patients with hypertonic discirculatory encephalopathy |
| Q36057508 | GFAP and antibodies against NMDA receptor subunit NR2 as biomarkers for acute cerebrovascular diseases |
| Q34330510 | Gene expression profiling of blood for the prediction of ischemic stroke |
| Q59804812 | Hyperacute changes in blood mRNA expression profiles of rats after middle cerebral artery occlusion: Towards a stroke time signature |
| Q37571237 | Invited article: searching for oracles? Blood biomarkers in acute stroke. |
| Q36323482 | Lessons from Metabonomics on the Neurobiology of Stroke. |
| Q46950395 | Machine-learning approach identifies a pattern of gene expression in peripheral blood that can accurately detect ischaemic stroke. |
| Q42380277 | MicroRNA 150-5p Improves Risk Classification for Mortality within 90 Days after Acute Ischemic Stroke. |
| Q37408830 | Molecular biomarkers in stroke diagnosis and prognosis |
| Q36571761 | Multiple liquid chromatography separations and nanoESI-ion trap detection of plasma proteins in search of stroke biomarkers: A pilot study. |
| Q38267991 | Nanotheragnostic applications for ischemic and hemorrhagic strokes: improved delivery for a better prognosis. |
| Q38270771 | Neuroendocrine hormones as prognostic biomarkers in the setting of acute stroke: overcoming the major hurdles. |
| Q54437633 | Neurosurgeons on the Front Line of Stroke Management: Spotting Stroke Chameleons. |
| Q37731462 | Parallel affinity-based isolation of leukocyte subsets using microfluidics: application for stroke diagnosis |
| Q90290330 | Plasma Lipid Profiling Identifies Biomarkers of Cerebral Microvascular Disease |
| Q37017515 | Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats |
| Q26781099 | Plasmatic markers for early diagnostic and treatment decisions in ischemic stroke |
| Q37903248 | Plasmatic markers in hemorrhagic stroke |
| Q37451522 | Potential biomarkers for the diagnosis of stroke |
| Q46760792 | Protein biomarkers for traumatic and ischemic brain injury: from bench to bedside |
| Q39684610 | Proteomic analysis of rat plasma following transient focal cerebral ischemia |
| Q38402930 | Recent and near-future advances in nucleic acid-based diagnosis of stroke |
| Q35881011 | Remote ischemic preconditioning in the prevention of ischemic brain damage during intracranial aneurysm treatment (RIPAT): study protocol for a randomized controlled trial |
| Q57045100 | Retrospective evaluation of a clinical decision support tool for effective computed tomography angiography utilization in urgent brain imaging of suspected TIA/minor stroke in the emergency department |
| Q96953595 | Role of DJ-1 in Immune and Inflammatory Diseases |
| Q52148657 | Serum Phenylalanine, Tyrosine, and their Ratio in Acute Ischemic Stroke: on the Trail of a Biomarker? |
| Q33959166 | Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality |
| Q33770773 | Soluble Urokinase-type Plasminogen Activator Receptor Predicts All-cause 5-Year Mortality in Ischemic Stroke and TIA. |
| Q94593108 | The Review of Transient Ischemic Attack Patients: An Experience of a Clinic about Diagnosis and Follow-up |
| Q38160586 | The accuracy of glial fibrillary acidic protein in acute stroke differential diagnosis: A meta-analysis. |
| Q47700375 | The role of stump pressure and cerebral oximetry in predicting ischaemic brain damage during carotid endarterectomy. |
| Q45350295 | The value of the serum neurofilament protein heavy chain as a biomarker for peri-operative brain injury after carotid endarterectomy |
| Q36779120 | Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review |
| Q35993214 | Translating basic science research to clinical application: models and strategies for intracerebral hemorrhage. |
| Q50992028 | Value of measuring serum vascular endothelial growth factor levels in diagnosing acute ischemic stroke. |